GSK chief executive Emma Walmsley is to step down after more than eight years running the pharmaceuticals giant.

WASHINGTON >> Pfizer and President Donald Trump on Tuesday said they had cut a deal in which the U.S.-based drugmaker agreed to lower prescription drug prices in the Medicaid program to what it ...

The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of ...

Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA ...

Shares in Indianapolis-based Eli Lilly and Co. were on the rise Wednesday after President Trump suggested the company would ...

GSK CEO Emma Walmsley will step down in 2025, with Luke Miels taking over as the company refocuses on pipeline growth and Montco operations.

A deal between Pfizer and former President Donald Trump is sending shockwaves through both the healthcare industry and Washington — ...

The agreement, seen as less punishing than some within the industry had feared, gives hard-hit global drugmakers a degree of clarity after a volatile year during which Trump has taken aim at the ...

The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

GSK Plc is “betting big on the US” and engaged in constructive talks on drug pricing with US President Donald Trump’s administration, according to Emma Walmsley, the outgoing chief executive officer ...

U.S. stocks climbed Monday as tech rebounded. S&P 500, Dow, and Nasdaq gained while investors await Friday’s key jobs report.